Trials / Completed
CompletedNCT01433120
Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Female
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Studies of the human gut microbiome have suggested that treatment or prevention aimed at the obese microbiome could influence the development of obesity-associated metabolic disturbances. The objective of this project is to explore if a dietary intervention in 60 obese women with the probiotic Lactobacillus paracasei ssp paracasei F19 or flax seed fibres targeting the gut microbiome, can reduce insulin resistance, low-grade inflammation or dyslipidaemia, and to explore the interaction between the human genome and the gut microbiome. The study is based on the following hypotheses: * Treatment with the probiotic Lactobacillus paracasei ssp paracasei F19 and flax seed fibres will lower the metabolic risk profile in the intervention groups compared with placebo. * The effect on the metabolic risk markers can be correlated with changes in the gut microbiota (measured in faeces). After completion of the dietary intervention, the participants are offered a 10-week weight reduction program. Those who participate in the weight-loss program are invited to an optional follow-up visit in connection with the last visit at the clinical dietician, for the purpose of exploring the effect of weight loss on the gut microbiota and obesity-associated metabolic disturbances.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus paracasei ssp paracasei F19 | 10\^10 CFU of Lactobacillus paracasei F19 (dissolved in a glass of water once per day) |
| DIETARY_SUPPLEMENT | Flax seed fibres | 10 grams of flax seed fibres per day (baked into two breakfast buns) |
| DIETARY_SUPPLEMENT | Maltodextrin (Placebo) | Maltodextrin is dissolved in a glas of water once per day |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-06-01
- Completion
- 2013-08-01
- First posted
- 2011-09-13
- Last updated
- 2014-06-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01433120. Inclusion in this directory is not an endorsement.